Live Analyst Rating Changes 1506 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Ryan Zimmerman
BTIG
Ryan Zimmerman
Wall Street Analyst
★☆☆☆☆
#2381
on 13Foresight · ranked by our own returns
45%
Success Rate
-5.7%
Average Return
18 of 40 calls profitable · -15.8% vs benchmark
📈 Across the calls we could measure, roughly 45% of Ryan Zimmerman's ratings turned a profit when each position was held for 1 year — averaging -5.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

147 Buy 77 Hold 3 Sell
Ryan's Stock Coverage 38 ratings · 2026-06-18
Company Date Position Consensus Price Target 1-Yr Return
GKOS
Glaukos
Jun 09, 2026 BUY Strong Buy
+7.8% avg upside
20 analysts
$162.00
27.16% Upside
·
SOLV
Solventum Corporation
Jun 09, 2026 BUY Buy
+15.4% avg upside
15 analysts
$89.00
19.46% Upside
-9.6%
MDT
Medtronic
Jun 04, 2026 BUY Buy
+24.9% avg upside
38 analysts
$90.00
15.14% Upside
-3.2%
MOBI
Mobia Medical, Inc.
Jun 02, 2026 BUY Strong Buy
+43.8% avg upside
4 analysts
$19.00
30.78% Upside
·
PRCT
PROCEPT BioRobotics
Jun 02, 2026 HOLD Buy
+85.2% avg upside
16 analysts
-16.5%
MDAI
Spectral AI
May 26, 2026 BUY Strong Buy
+152.9% avg upside
3 analysts
$4.00
120.91% Upside
-20.2%
TCMD
Tactile Systems Technology
May 21, 2026 BUY Strong Buy
+58.8% avg upside
8 analysts
$40.00
54.85% Upside
+2.6%
RCEL
Avita Medical
May 14, 2026 HOLD Strong Buy
+158.3% avg upside
10 analysts
+2.8%
STAA
Staar Surgical
May 14, 2026 HOLD Hold
+14.0% avg upside
16 analysts
-10.5%
SI
Shoulder Innovations, Inc.
May 13, 2026 BUY Strong Buy
+16.9% avg upside
5 analysts
$24.00
33.64% Upside
+41.1%
ORGO
Organogenesis Holdings
May 08, 2026 HOLD Strong Buy
+392.7% avg upside
8 analysts
+4.2%
RXST
RxSight
May 07, 2026 HOLD Hold
+138.1% avg upside
13 analysts
+3.5%
CARL
Carlsmed, Inc.
May 06, 2026 BUY Strong Buy
+84.3% avg upside
5 analysts
$23.00
130.52% Upside
+11.1%
SYK
Stryker
May 01, 2026 BUY Strong Buy
+25.2% avg upside
36 analysts
$379.00
25.87% Upside
+3.0%
KIDS
OrthoPediatrics
May 01, 2026 BUY Strong Buy
+64.3% avg upside
10 analysts
$24.00
32.16% Upside
+14.0%
ISRG
Intuitive Surgical
Apr 22, 2026 BUY Strong Buy
+30.5% avg upside
36 analysts
$574.00
42.68% Upside
-13.8%
GEHC
GE Healthcare Technologies Inc
Apr 21, 2026 BUY Strong Buy
+36.6% avg upside
20 analysts
$85.00
38.95% Upside
-9.8%
ENOV
Enovis
Apr 13, 2026 BUY Strong Buy
+230.7% avg upside
37 analysts
$39.00
86.98% Upside
+0.1%
VCEL
Vericel
Apr 05, 2026 HOLD Strong Buy
+15.2% avg upside
16 analysts
-3.2%
LNSR
LENSAR
Mar 31, 2026 BUY Strong Buy
+99.4% avg upside
4 analysts
$7.00
11.80% Upside
+1.5%
XTNT
Xtant Medical Holdings
Mar 31, 2026 BUY Strong Buy
+1457.7% avg upside
9 analysts
$1.00
128.95% Upside
-17.9%
CH:ALC
Alcon
Mar 23, 2026 BUY Buy
+35.5% avg upside
35 analysts
$72.91
41.42% Upside
·
ZBH
Zimmer Biomet Holdings
Mar 23, 2026 HOLD Buy
+28.0% avg upside
37 analysts
+1.4%
HUMA
Humacyte
Mar 19, 2026 BUY Strong Buy
+642.9% avg upside
11 analysts
$6.00
519.23% Upside
+23.5%
GMED
Globus Medical
Feb 25, 2026 HOLD Strong Buy
+26.0% avg upside
24 analysts
-16.4%
IART
Integra Lifesciences
Feb 18, 2026 HOLD Buy
+139.2% avg upside
21 analysts
+46.8%
PEN
Penumbra
Feb 18, 2026 HOLD Buy
+4.7% avg upside
23 analysts
-7.0%
RBOT
Vicarious Surgical
Nov 13, 2025 HOLD Buy
+5221.9% avg upside
6 analysts
-84.6%
TMCI
Treace Medical Concepts
Nov 07, 2025 HOLD Hold
+29.8% avg upside
8 analysts
-60.1%
OFIX
Orthofix Medical
Feb 25, 2025 HOLD Strong Buy
+214.2% avg upside
15 analysts
-25.5%
IRTC
Irhythm Technologies
Oct 16, 2023 BUY Strong Buy
+64.7% avg upside
19 analysts
$132.00
29.77% Upside
-26.8%
AXGN
AxoGen
Aug 18, 2023 HOLD Strong Buy
-25.6% avg upside
21 analysts
+104.0%
PODD
Insulet
Apr 17, 2023 BUY Strong Buy
+81.1% avg upside
32 analysts
$350.00
143.85% Upside
-48.2%
GE
GE Aerospace
Apr 10, 2023 HOLD Strong Buy
-35.8% avg upside
49 analysts
+108.4%
MDWD
Mediwound
Oct 14, 2022 HOLD Strong Buy
+52.4% avg upside
13 analysts
-3.7%
ECOR
Electrocore
Jul 30, 2021 HOLD Strong Buy
+535.7% avg upside
10 analysts
-44.6%
ABT
Abbott Laboratories
Aug 27, 2020 HOLD Strong Buy
+30.9% avg upside
35 analysts
+13.6%
OCGN
Ocugen
Dec 24, 2018 HOLD Strong Buy
+643.8% avg upside
17 analysts
-95.0%
🔒 33 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Ryan Zimmerman — Frequently Asked Questions
How accurate are Ryan Zimmerman's stock ratings?
Based on the calls 13Foresight could measure, about 45% of Ryan's ratings were profitable over a one-year hold, with an average return of -5.7% per rating, or -15.8% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Ryan ranked on 13Foresight?
Ryan Zimmerman is currently ranked #2381 with a 1-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Ryan cover?
Ryan most recently has ratings on GKOS, SOLV, MDT, MOBI, PRCT, MDAI, TCMD, RCEL, STAA, SI, ORGO, RXST and 26 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.